YOUR BUSINESS AUTHORITY
Springfield, MO
Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.
Novartis is offering $73 per share, a premium of around 142%.
Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.
Read more from Quartz.
Organizers hope to bolster client traffic to center city businesses.
AI expert gives advice at SBJ's People You Need to Know
European-style Christmas market to make debut in Branson next week
Big Cedar Lodge golf courses place on Golfweek list
Original, historic Pipkin building up for sale
Pizza Hut co-founder Dan Carney dies
Annual downtown holiday events combine for Nov. 21 celebration